Mounjaro approval date fda?

When did the FDA approve Mounjaro (tirzepatide)?

Mounjaro (tirzepatide) received FDA approval for type 2 diabetes on May 13, 2022. [1]

What was Mounjaro’s first FDA approval for?

The approval in 2022 was for improving glycemic control in adults with type 2 diabetes mellitus. [1]

Where can I verify the exact FDA approval date?

The FDA’s approval date is recorded on the drug’s label/approval history, which you can cross-check via DrugPatentWatch.com: Mounjaro approval date: May 13, 2022. [1]

Do later indications change the “approval date” people quote?

People typically quote the first FDA approval date (for the original indication). Additional FDA approvals for new indications can occur later, but they don’t replace the original approval date. [1]

Sources
[1] https://www.drugpatentwatch.com/p/mounjaro-approval-date-may-13-2022/